Literature DB >> 24266758

Enhanced synthesis and release of dopamine in transgenic mice with gain-of-function α6* nAChRs.

Yuexiang Wang1, Jang-Won Lee, Gyeon Oh, Sharon R Grady, J Michael McIntosh, Darlene H Brunzell, Jason R Cannon, Ryan M Drenan.   

Abstract

α6β2* nicotinic acetylcholine receptors (nAChRs)s in the ventral tegmental area to nucleus accumbens (NAc) pathway are implicated in the response to nicotine, and recent work suggests these receptors play a role in the rewarding action of ethanol. Here, we studied mice expressing gain-of-function α6β2* nAChRs (α6L9'S mice) that are hypersensitive to nicotine and endogenous acetylcholine. Evoked extracellular dopamine (DA) levels were enhanced in α6L9'S NAc slices compared to control, non-transgenic (non-Tg) slices. Extracellular DA levels in both non-Tg and α6L9'S slices were further enhanced in the presence of GBR12909, suggesting intact DA transporter function in both mouse strains. Ongoing α6β2* nAChR activation by acetylcholine plays a role in enhancing DA levels, as α-conotoxin MII completely abolished evoked DA release in α6L9'S slices and decreased spontaneous DA release from striatal synaptosomes. In HPLC experiments, α6L9'S NAc tissue contained significantly more DA, 3,4-dihydroxyphenylacetic acid, and homovanillic acid compared to non-Tg NAc tissue. Serotonin (5-HT), 5-hydroxyindoleacetic acid, and norepinephrine (NE) were unchanged in α6L9'S compared to non-Tg tissue. Western blot analysis revealed increased tyrosine hydroxylase expression in α6L9'S NAc. Overall, these results show that enhanced α6β2* nAChR activity in NAc can stimulate DA production and lead to increased extracellular DA levels.
© 2013 International Society for Neurochemistry.

Entities:  

Keywords:  Parkinson's disease; addiction; cholinergic; dopamine; nicotinic; nucleus accumbens

Mesh:

Substances:

Year:  2013        PMID: 24266758      PMCID: PMC3980028          DOI: 10.1111/jnc.12616

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  58 in total

1.  Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior.

Authors:  B N Cohen; E D W Mackey; S R Grady; S McKinney; N E Patzlaff; C R Wageman; J M McIntosh; M J Marks; H A Lester; R M Drenan
Journal:  Neuroscience       Date:  2011-11-04       Impact factor: 3.590

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

3.  Activation of tyrosine hydroxylase by nicotine in rat adrenal gland.

Authors:  L H Fossom; C Sterling; A W Tank
Journal:  J Neurochem       Date:  1991-12       Impact factor: 5.372

4.  A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions.

Authors:  S I Walaas; D W Aswad; P Greengard
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

5.  Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors.

Authors:  Ryan M Drenan; Sharon R Grady; Andrew D Steele; Sheri McKinney; Natalie E Patzlaff; J Michael McIntosh; Michael J Marks; Julie M Miwa; Henry A Lester
Journal:  J Neurosci       Date:  2010-07-21       Impact factor: 6.167

Review 6.  Nicotine and Parkinson's disease: implications for therapy.

Authors:  Maryka Quik; Kathryn O'Leary; Caroline M Tanner
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

7.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

8.  Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine.

Authors:  Tianxiang Zhang; Lifen Zhang; Yong Liang; Athanassios G Siapas; Fu-Ming Zhou; John A Dani
Journal:  J Neurosci       Date:  2009-04-01       Impact factor: 6.167

9.  α4α6β2* nicotinic acetylcholine receptor activation on ventral tegmental area dopamine neurons is sufficient to stimulate a depolarizing conductance and enhance surface AMPA receptor function.

Authors:  Staci E Engle; Pei-Yu Shih; J Michael McIntosh; Ryan M Drenan
Journal:  Mol Pharmacol       Date:  2013-06-20       Impact factor: 4.436

10.  Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons.

Authors:  Sarah Threlfell; Tatjana Lalic; Nicola J Platt; Katie A Jennings; Karl Deisseroth; Stephanie J Cragg
Journal:  Neuron       Date:  2012-07-12       Impact factor: 17.173

View more
  13 in total

1.  Evidence for a role for α6(∗) nAChRs in l-dopa-induced dyskinesias using Parkinsonian α6(∗) nAChR gain-of-function mice.

Authors:  T Bordia; M McGregor; J M McIntosh; R M Drenan; M Quik
Journal:  Neuroscience       Date:  2015-03-24       Impact factor: 3.590

2.  The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Authors:  Jeffrey S Wieskopf; Jayanti Mathur; Walrati Limapichat; Michael R Post; Mona Al-Qazzaz; Robert E Sorge; Loren J Martin; Dmitri V Zaykin; Shad B Smith; Kelen Freitas; Jean-Sebastien Austin; Feng Dai; Jie Zhang; Jaclyn Marcovitz; Alexander H Tuttle; Peter M Slepian; Sarah Clarke; Ryan M Drenan; Jeff Janes; Shakir Al Sharari; Samantha K Segall; Eske K Aasvang; Weike Lai; Reinhard Bittner; Christopher I Richards; Gary D Slade; Henrik Kehlet; John Walker; Uwe Maskos; Jean-Pierre Changeux; Marshall Devor; William Maixner; Luda Diatchenko; Inna Belfer; Dennis A Dougherty; Andrew I Su; Sarah C R Lummis; M Imad Damaj; Henry A Lester; Ardem Patapoutian; Jeffrey S Mogil
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

3.  Subacute manganese exposure in rats is a neurochemical model of early manganese toxicity.

Authors:  Stefanie L O'Neal; Jang-Won Lee; Wei Zheng; Jason R Cannon
Journal:  Neurotoxicology       Date:  2014-08-10       Impact factor: 4.294

4.  Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment.

Authors:  Philip A Adeniyi; Azeez O Ishola; Babafemi J Laoye; Babawale P Olatunji; Oluwamolakun O Bankole; Philemon D Shallie; Olalekan M Ogundele
Journal:  Metab Brain Dis       Date:  2015-06-20       Impact factor: 3.584

5.  The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.

Authors:  Jirawoot Srisontiyakul; Hanna E Kastman; Elena V Krstew; Piyarat Govitrapong; Andrew J Lawrence
Journal:  Neurochem Res       Date:  2016-08-29       Impact factor: 3.996

6.  Alterations in the nigrostriatal dopamine system after acute systemic PhIP exposure.

Authors:  Zeynep Sena Agim; Jason R Cannon
Journal:  Toxicol Lett       Date:  2018-01-31       Impact factor: 4.372

7.  α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity.

Authors:  J N Berry; S E Engle; J M McIntosh; R M Drenan
Journal:  Neuroscience       Date:  2015-07-23       Impact factor: 3.590

8.  r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement.

Authors:  Joshua S Beckmann; Andrew C Meyer; M Pivavarchyk; David B Horton; Guangrong Zheng; Andrew M Smith; Thomas E Wooters; J Michael McIntosh; Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Neurochem Res       Date:  2015-07-31       Impact factor: 3.996

9.  Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats.

Authors:  Jang-Won Lee; Victor Tapias; Roberto Di Maio; J Timothy Greenamyre; Jason R Cannon
Journal:  Neurobiol Aging       Date:  2014-07-15       Impact factor: 4.673

Review 10.  Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement.

Authors:  Carole Morel; Sarah Montgomery; Ming-Hu Han
Journal:  Eur J Neurosci       Date:  2018-10-15       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.